UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 25, 2017 4:30 P.M.
Form:
S-3
CIK:
0001504167
Company Name:
BioPharmX Corp
File Number:
333-220012